Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-438219
Filing Date
2013-11-12
Accepted
2013-11-12 16:03:19
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d596749d10q.htm 10-Q 474744
2 EX-31.1 d596749dex311.htm EX-31.1 6527
3 EX-31.2 d596749dex312.htm EX-31.2 6559
4 EX-32.1 d596749dex321.htm EX-32.1 5556
  Complete submission text file 0001193125-13-438219.txt   3666815

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT celphap-20130930.xml EX-101.INS 497348
6 XBRL TAXONOMY EXTENSION SCHEMA celphap-20130930.xsd EX-101.SCH 38485
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celphap-20130930_cal.xml EX-101.CAL 59971
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celphap-20130930_def.xml EX-101.DEF 123625
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE celphap-20130930_lab.xml EX-101.LAB 315231
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celphap-20130930_pre.xml EX-101.PRE 211002
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36179 | Film No.: 131210155
SIC: 2834 Pharmaceutical Preparations